Google
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
NIRVANA LIFE SCIENCES INC. |
Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
| 0.0350 CAD | +16.67% | +16.67% | -76.67% | |
| Sales 2023 * | - | Sales 2024 * | - | Capitalization | 1.02 M 1.38 M |
|---|---|---|---|---|---|
| Net income 2023 | -1,000,000 -1.35 M | Net income 2024 * | - | EV / Sales 2023 | - |
| Net Debt 2023 | 45,905 61,953 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | - |
| P/E ratio 2023 | -0,68x | P/E ratio 2024 * | Employees | - | |
| Yield 2023 | - | Yield 2024 * |
-
| Free-Float | 44.21% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +16.67% | ||
| 1 week | +16.67% | ||
| 1 month | +16.67% | ||
| 3 months | -56.25% | ||
| Current year | -76.67% |
1 week
0.04
0.04
1 month
0.030.04
Current year
0.020.18
1 year
0.020.18
3 years
0.020.95
5 years
0.020.95
10 years
0.020.95
| Managers | Title | Age | Since |
|---|---|---|---|
Bruce Clark
CEO | Chief Executive Officer | 62 | 2017 |
Annie Storey
DFI | Director of Finance/CFO | - | 2017 |
Michael McCune
COO | Chief Operating Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 67 | Nov. 08 | |
Annie Storey
DFI | Director of Finance/CFO | - | 2017 |
| Director/Board Member | - | 2017 |
| Date | Price | Change | Volume |
|---|
Delayed Quote Canadian Securities Exchange, November 27, 2023 at 01:26 pm EST
More quotes
Nirvana Life Sciences Inc. is a Canada-based company, which is engaged in the scientific research and development of therapeutic products derived from psychedelics. The Company is also focused on developing methodologies for standardized, quality-controlled extraction and purification of psychoactive compounds. The Company operates in a single segment: research and development of therapeutic products derived from psychedelics. The Company products include Two Products and Therapeutic Products. Two Products is a one-per-day slow-release gel cap that assists the transition from opioids to non-addictive pain relief therapies. The Company is also engaged in growing several genera and species of fungi (including rare and hybrid varieties) with a batch consistency.
Calendar
2023-12-17
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -76.67% | 1 M $ | |
| +65.53% | 40 225 M $ | |
| +5.87% | 39 073 M $ | |
| -55.56% | 29 626 M $ | |
| -26.11% | 28 824 M $ | |
| +38.66% | 21 976 M $ | |
| -27.87% | 21 114 M $ | |
| +1.62% | 17 420 M $ | |
| -13.43% | 11 278 M $ | |
| -7.44% | 10 110 M $ |
